Cargando…
Drug-induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms Caused by Lenalidomide: Case Report and Review of the Literature
Autores principales: | OSADA, Shin-Ichi, SATO, Takahiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Society for Publication of Acta Dermato-Venereologica
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367031/ https://www.ncbi.nlm.nih.gov/pubmed/34027556 http://dx.doi.org/10.2340/00015555-3835 |
Ejemplares similares
-
Recent Advances in Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms
por: Watanabe, Hideaki
Publicado: (2018) -
Correlation Between Expression of CD134, a Human Herpesvirus 6 Cellular Receptor, on CD4(+) T cells and Th2-type Immune Responses in Drug-induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms
por: MIYAGAWA, Fumi, et al.
Publicado: (2020) -
Influence of corticosteroid therapy on viral reactivation in drug‐induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms
por: Tohyama, Mikiko, et al.
Publicado: (2020) -
Current Perspective Regarding the Immunopathogenesis of Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms (DIHS/DRESS)
por: Miyagawa, Fumi, et al.
Publicado: (2021) -
Immune reconstitution inflammatory syndrome observed in the setting of drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS)
por: Kano, Yoko, et al.
Publicado: (2014)